Having invested in Q4 2025, we are pleased to see this key seed round come together just as the next generation platform is launching. It enables women to manage their healthcare, with a key focus on reproductive health.
www.linkedin.com/posts/mystor...
A shout out to our Venture Partner, Melissa Durrell @melissadurrell.bsky.social who launched a program on Women's Day to support women entrepreneurs.
www.cbc.ca/news/canada/...
Breaking News! Portfolio company Vena Medical has been awarded US @fda.gov approval for their Vena MicroAngioscope System™, a maor milestone. To take advantage and drive commercialization, they have opened a Kitchener-based Manufacturing Centre of Excellence.
www.linkedin.com/posts/vename...
As highlighted in the recent NACO Roundtable on early stage investing, unlocking more capital is critical to our success. This report, will make everyone pause, as it puts a massive price on our failure to properly fund our new startups.
thelogic.co/news/canada-...
The recent NACO National Roundtable from Thursday February 19th is now available as a podcast, with the audio from that session.
podcast.nacocanada.com/791204/episo...
Our General Partner, Randall Howard who has worked to build VERDEXUS, GTAN angel network, Archangel Network of Funds will engage with other leaders on this generational opportunity to close this gap. Registration in the link to the NACO site and is now approaching 1000 attendees.
Excited to join the ABR seed round, directly advancing our mission to enable our investors to directly help accelerat Canadian IP-based startups into global markets. ABR transforms edge AI applications. Kudos to Kevin Conley, Chris Eliasmith and the entire team.
www.prnewswire.com/news-release...
Adrenaline is one of the 4 funds comprising Archangel Network of Funds. Here are some thoughts as we enter 2026. Collectively, Archangel funds have completed over 120 investments into 80 unique companies helping fill Canada's pressing 'seed gap' in funding our future
www.linkedin.com/posts/archan...
This is a complex issue, involving many components. For investment, the gap (yawning chasm) is in the early stage (pre Series A). At Adrenaline, unlike many Canadian funds, we invest ONLY in Canadian startups at the rate of 10 a year. We are doing our part
thelogic.co/news/venture...
Totally agree that a few AI companies are in a bubble many times the Dot Com meltdown. Unlike that time, also strongly believe this has undervalued many other tech theses (incl. AI-driven SaaS) fuelling our conviction that now is perfect for early stage investment
www.saastr.com/the-1-5-tril...
Is this the turning point for VC liquidity? More IPOs, interest rates continuing down, and more. All drive follow on rounds and M&A for early stage companies.
pitchbook.com/news/article...
Looking forward to an important discu0ssion at #NACOSummit moderated by @randallh.bsky.social our General Partner
www.linkedin.com/posts/randal...
This is a huge win for our portfolio company Eleven-x as it transforms the parking landscape
#ClimateTech
eleven-x.com/company/news...
CSE public company Treatment.com AI Inc (CSE:TRUE, Frankfurt: TREIF) has signed an agreement to acquire our portfolio company @rocketdoctor.bsky.social
The combination means that two clinician-led digital health solution providers are joining forces.
www.globenewswire.com/news-release...
BREAKING. Our portfolio company VoxCell BioInnovation won LEAP Landing Award at the major global event in Saudi Arabia. Congratulations to founder, CEO Karolina Valente and the entire team. And for sure the US$150,000 non-dilutive prize will further help you deliver on this huge opportunity.
Canadians powering a diversified and dynamic economy by investing in Canadian startups.
Go #TeamCanada
We were pleased that our general partners, @randallh.bsky.social and Benton Leong were able to share wisdom about best practices in angel investment at a recent Brampton Angels panel. The summary provides should help others learn and grow angel capacity.
www.linkedin.com/posts/brampt...
Great article in Waterloo Region Record covering GTAN with a shout out to how we work with the Angel ecosystem
HDAX Therapeutics is a company on the move recently added to our portfolio. Amazing to support co-founders Nabanita Nawar, Pimyupa Manaswiyoungkul and their team as they pioneer next gen precision therapeutics targeting cardiovascular disease and neuropathies.
www.linkedin.com/posts/hdaxtx...
. . .We believe we optimize for this winning combination of confidence and competence in those leading our portfolio.
4 / 4
. . . experienced investors our model assesses emotional intelligence and coachability helping avoid over confidence (hubris). Secondly, requiring experienced business investors ("qualified leads") be active in the company post investment involve with "powerful and expert boards." . .
3 / 4
That confidence is often challenged by Canada's lack of early stage capital fuelled by risk aversion. Adrenaline Fund has a mission to work with ecosystem to close that gap.
Our rules-based approach is validated by the research on confidence in (founder) CEOs. Firstly, by leveraging other . ,
2 / 4
Canadians have often been seen as being highly risk averse - and it's often cited as a barrier to investment and future productivity. Not so in the world of startups, where Canadian founders aspire to bend the universe with world beating confidence.[Paywall]
1 /4
www.economist.com/business/202...
